
Vera A Bittner MD
Nuclear Cardiology, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation, Cardiac Critical Care
Professor, Medicine, University of Alabama School of Medicine
Join to view full profile
2000 6th Ave SBirmingham, AL 35233
Phone+1 205-934-9999
Dr. Bittner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Section Head, Preventive Cardiology
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Cardiovascular Disease, 1984 - 1987
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1981 - 1984
University of South Alabama College of MedicineClass of 1981
Certifications & Licensure
AL State Medical License 1984 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.Dmitry Abramov, Abdul Mannan Khan Minhas, Michael D Shapiro, Vera A Bittner, LaPrincess C Brewer
Current Atherosclerosis Reports. 2026-06-15 - Lipoprotein(a)-associated proteomic signature predicts cardiovascular disease in young adults.Sascha N Goonewardena, Shanshan Yao, Tomasz Jurga, Lanyue Zhang, Donald Lloyd-Jones
The Journal of Clinical Investigation. 2026-06-15 - Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment.Gregory G Schwartz, Michael Szarek, Christa M Cobbaert, L Renee Ruhaak, Markus Schwertfeger
American Journal of Preventive Cardiology. 2026-06-01
Journal Articles
- Original Investigations Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialVera Bittner, MD, ScienceDirect
- Alirocumab and Cardiovascular Outcomes After Acute Coronary SyndromeVera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
- Do Not Smoke, Eat Healthy, and ExerciseVera Bittner, MD, JACC: Cardiovascular Imaging
Lectures
- Lipoprotein(a) Lowering by Alirocumab Contributes to Total Events Reduction Independent of Low-Density Lipoprotein Cholesterol in the ODYSSEY OUTCOMES Trial2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Late-Breaking Clinical Trials2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Hypertension Management Hypercharged: The Devil is in the Details2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- Do Not Smoke, Eat Healthy, and ExerciseNovember 2018
- Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United StatesApril 2018
- Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United StatesApril 2018
Press Mentions
UAB Heart Failure Clinic Recognized Nationally for Its ExcellenceOctober 21st, 2025
HRTSA Clinic Recognized NationallyOctober 7th, 2025
UAB Cardiovascular Institute Earns Top Heart Failure Care AwardOctober 6th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









